The best treatment for type 2 diabetes depends on your specific situation, but for most people it starts with metformin combined with lifestyle changes, then builds from there based on your weight, heart health, kidney function, and blood sugar levels. The goal is an A1C below 7% for most adults, though your doctor may adjust that target based on your age and health history. What’s changed dramatically in recent years is that newer medications can now protect your heart and kidneys while also driving significant weight loss, making treatment far more effective than it was even a decade ago.
Why Metformin Is Still the Starting Point
Metformin has been the first-line medication for type 2 diabetes for decades, and it holds that position for good reason. It lowers A1C by about 1.1% on average when used alone, and by about 1% when added to another oral medication. It’s inexpensive, well-studied over decades of use, and carries a low risk of causing dangerously low blood sugar. It works by reducing the amount of sugar your liver releases into your bloodstream and by helping your cells respond better to insulin.
Most people tolerate metformin well, though stomach upset and diarrhea are common in the first few weeks. Starting at a low dose and increasing gradually, or using the extended-release version, usually helps. For many people with newly diagnosed type 2 diabetes and an A1C that isn’t dramatically elevated, metformin plus lifestyle changes is enough to reach their target. But when it’s not, the next step matters more now than it used to.
Newer Medications That Go Beyond Blood Sugar
Two classes of newer drugs have fundamentally changed how type 2 diabetes is treated. These aren’t just blood sugar medications. They protect against heart attacks, strokes, and kidney disease, which are the complications that make diabetes dangerous in the first place.
The first class works by mimicking a gut hormone that triggers insulin release after meals, slows digestion, and reduces appetite. These medications are given as weekly or daily injections. The second class works in the kidneys, causing excess sugar to leave the body through urine, which also lowers blood pressure and reduces strain on the heart and kidneys. These are taken as daily pills.
When researchers modeled the effects of combining both classes, the projected results were striking: a 22% reduction in the risk of major cardiovascular events like heart attacks and strokes, and a 51% reduction in the risk of kidney disease progression. If you have existing heart disease, heart failure, or chronic kidney disease, current guidelines recommend adding one or both of these medication classes regardless of your A1C level, because the organ protection they offer is independent of blood sugar control.
Weight Loss as a Treatment Effect
These newer medications also produce meaningful weight loss, which directly improves insulin resistance. In a head-to-head trial of over 1,870 people with type 2 diabetes, the dual-acting injectable (tirzepatide) reduced A1C by 2% to 2.3% and produced average weight loss of 17 to 25 pounds over 40 weeks. The single-acting injectable (semaglutide) reduced A1C by 1.9% with an average weight loss of 13 pounds over the same period. Both results are far beyond what metformin alone achieves.
The most common side effects of these injectable medications are nausea, vomiting, and diarrhea, especially when starting or increasing the dose. Combination therapy with both newer drug classes carries a higher rate of low blood sugar (about 1.8 times the risk compared to using either alone), along with more frequent nausea, genital infections from the kidney-acting pill, and irritation at injection sites. These side effects are generally mild, and no increase in severe adverse events has been found with combination use.
Lifestyle Changes That Drive Real Results
Medication works best when paired with changes to how you eat and move, and in some cases, lifestyle changes alone can put type 2 diabetes into remission. The landmark DiRECT trial in the UK tested a structured weight management program in people who had been diagnosed within the past six years and weren’t yet on insulin. At 12 months, 46% of participants achieved full remission, meaning their blood sugar returned to non-diabetic levels without medication.
The key factor was weight loss. Among those who lost more than 33 pounds, over 80% were in remission. Even losing 22 pounds pushed remission rates to 75%. These aren’t abstract numbers. They show that for people early in their diabetes journey, aggressive weight loss can effectively reverse the condition, at least for a period of time. The challenge is maintaining that loss. Structured support, whether through a formal program, dietitian, or behavioral coaching, makes a significant difference in long-term success.
The most impactful dietary changes focus on reducing refined carbohydrates and processed foods while increasing fiber, vegetables, and lean protein. You don’t need to follow one specific diet. Mediterranean, low-carb, and plant-based eating patterns have all shown benefits. What matters most is finding an approach you can sustain. On the exercise side, both aerobic activity (walking, cycling, swimming) and resistance training (weights, bodyweight exercises) independently improve how your body uses insulin. Aim for at least 150 minutes of moderate activity per week, spread across most days.
When Surgery Becomes the Best Option
For people with type 2 diabetes and a BMI of 35 or higher, metabolic surgery (commonly called bariatric surgery) produces results that no medication can match. In a randomized trial comparing surgery to intensive medical therapy, 42% of gastric bypass patients and 37% of sleeve gastrectomy patients reached an A1C of 6.0% or below at 12 months. Only 12% of patients on intensive medication alone hit that target.
Surgery also improved cholesterol, blood pressure, and other cardiovascular risk factors enough to reduce the need for heart and blood pressure medications. Guidelines now recommend considering metabolic surgery for people with a BMI over 35 who haven’t reached their blood sugar goals with medication, and some guidelines extend that recommendation to people with a BMI as low as 30 when diabetes is poorly controlled. Recovery from sleeve gastrectomy typically takes two to four weeks before returning to normal activity, with a gradual transition from liquid to solid foods over several weeks.
How Treatment Is Personalized
There is no single best treatment because type 2 diabetes varies enormously from person to person. A 45-year-old diagnosed last year with an A1C of 7.5% and no complications has a completely different treatment path than a 68-year-old with heart failure, kidney disease, and an A1C of 9%. The American Diabetes Association emphasizes that A1C targets should be individualized. While below 7% is the general benchmark, a tighter target (below 6.5%) may make sense for younger people early in their disease, and a more relaxed target (below 8%) may be appropriate for older adults or those with multiple health conditions where the risk of low blood sugar outweighs the benefit of tight control.
Your treatment plan will likely evolve over time. Type 2 diabetes is progressive, meaning the insulin-producing cells in your pancreas gradually lose function. A treatment that works well for years may eventually need to be intensified. This isn’t a failure on your part. It’s the natural course of the disease. The most important factors in long-term outcomes are keeping your blood sugar reasonably controlled, protecting your heart and kidneys with the right medications, and maintaining a healthy weight. Starting the right combination of treatments early, rather than waiting until complications develop, gives you the best chance of living well with this condition for decades.